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The major proposed intermediates through which valine is 
synthesized from pyruvate in viva are depicted in Fig. 1. Iso- 
leucine is formed by a similar sequence of reactions from pyru- 
vate and cu-ketobutyrate via ac-aceto-c-r-hydroxybutyrate (for 
literature, see (2)). Although Reactions I, V, and VI of Fig. 1 
have been studied at the enzymatic level, the unusual isomeriza- 
tion and reduction step by which ac-acetolactate is converted to 
cr&dihydroxyisovalerate has not been studied as an isolated 
reaction, and it is uncertain whether this conversion proceeds in 
two steps (Reactions II + III) or in a single step (Reaction IV). 
Strassman et al. (3, 4) and later Meister (5) pointed out the 
possible role of oc-keto-/3-hydroxyisovalerate as an intermedi- 
ate during this reaction. il two-step reaction was made more 
likely by the findings of Wagner et al. (6) that Neurospora crassa 
contained an enzyme that catalyzed the conversion of ac-keto-/3- 
hydroxyisovalerate and cY-keto-fi-hydroxy-P-methylvalerate to 
the corresponding dihydroxy acids (Reaction III, Fig. 1). How- 
ever, further work has resulted in complete separation of the 
reductase catalyzing Reaction III from the recluctoisomerase that 
catalyzes Reaction IV. These results together with various 
properties of the two enzymes are presented in this article. 
EXPERIMENTAL PROCEDURE 
Preparation and Characterization of cr-Keto-@hydroxyisovalerate 
and a-Keto-fi-hydroxy-fl-methylvalerate-These oc-keto+hydroxy 
acids were synthesized from ar-ketoisovalerate and cY-keto+ 
methylvalerate by application of the procedure described by 
Sprinson and Chargaff (7) for the preparation of hydroxypyru- 
vate from pyruvate. The starting oc-keto acids were enzymat- 
ically prepared from the corresponding amino acids (8). Later, 
commercially available a-ketoisovalerate (Sigma Chemical Com- 
pany, 87% pure) was recrystallized once from acetone-water to 
give the pure compound. 
A typical preparation of ac-keto-/3-hydroxyisovalerate (HKV)’ 
* Supported in part by a grant (E-1575) from the United States 
Public Health Service. For Paper II of this series, see (1). 
t Present address, Department of Biochemistry, Indian Insti- 
tute of Science, Bangalore, India. Reprint requests should be 
addressed to Dr. E. E. Snell, Department of Biochemistry, Uni- _ 
versity of California, Berkeley 4, California. 
t John Simon Guggenheim Memorial Fellow. 1957-58. Present 
ad&ess, DepartmeG-of Zoology, University oi Texas, Austin 12, 
Texas. Dr. Wagner participated only in the experiments dealing 
with the a-keto-p-hydroxy acid reductase. 
1 Occasional use is made of the following abbreviations: a-keto- 
p-hydroxyisovalerate, HKV; a-keto-fl-hydroxy-fi-methylvalerate, 
HKI; a,fi-dihydroxyisovalerate, DHV; a,&dihydroxy-P-methyl- 
valerate, DHI; or-acetolactate, AL; a-aceto-a-hydroxybutyrate, 
AHB. 
was as follows. A solution of sodium clc-ketoisovalerate (4.14 g, 
0.03 moles) in a small volume of water was acidified with 2 N 
H&O4 and extracted continuously with ether. The ether extract 
was dried over anhydrous sodium sulfate, decanted, and freed of 
ether by evaporation in a vacuum. The free keto acid was dried 
over phosphorus pentoxide in a vacuum (yield 3.06 g, 88 ‘%), then 
warmed to 50”. Careful, dropwise addition of 1.56 ml of dry 
bromine resulted in a vigorous reaction with liberation of HBr. 
After completion of the addition (about 5 minutes), the flask 
was transferred to a vacuum desiccator containing moist pellets of 
NaOH, which was evacuated with a water pump. at-Keto-@- 
bromoisovaleric acid solidified as a crystalline cake in the flask. 
It was dissolved in a small amount of benzene and the solution 
evaporated to dryness. This was repeated twice; then, the com- 
pound was left in an evacuated desiccator for 2 days with occa- 
sional changes of the moist pellets of NaOH to remove the last 
traces of HBr. The yield was 5.1 g. (lOOa/,). Recrystallization 
from chloroform-petroleum ether gave shining platelets of the 
hygroscopic bromocompound. This was converted to the cor- 
responding a-keto-fl-hydroxy acid by dissolving in a small amount 
of water, and adding 2.5 N NaOH, rapidly until the pH reached 
6.0, then gradually, to maintain the pH between 7.0 and 8.5. 
The addition was stopped when hydrolysis was complete, as in- 
dicated by no further decrease in pH. Two equivalents of alkali 
were required. The resulting solution of cr-keto$-hydroxyiso- 
valerate was adjusted to pH 7.5 and was used without further 
purification. 
ac-Keto-b-hydroxy-@-methylvalerate (HKI) was prepared in a 
similar way from c-r-keto$-methylvalerate in excellent yields. 
The product was optically inactive, probably as a result of race- 
mization during bromination. The chromatographic properties 
of these two acids in various solvents have been reported (6). 
Some of the earlier preparations of the two ketohydroxy acids 
contained small amounts of the corresponding products of oxida- 
tive decarboxylation, a-hydroxyisobutyric acid or cr-hydroxy-ar- 
methylbutyric acid. These were identified by paper chromato- 
graphic comparison with authentic samples prepared in larger 
quantities by decarboxylation of the two oc-keto-fi-hydroxy acids 
with ceric sulfate (8) and isolation of the products. The forma- 
tion of these contaminants during preparation of the ketohydroxy 
acids was traced to a failure to maintain anhydrous conditions 
during the bromination step. When the starting keto acid was 
dried thoroughly over phosphorus pentoxide in a vacuum, even 
at the risk of losses due to volatilization, the final preparations 
were free of the contaminating hydroxy acids. 
Oxidative decarboxylation of the uncontaminated ketohydroxy 
acids with ceric sulfate (8) gave the expected values for CO2 
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evolution2 The products were further characterized by prep- 
aration of the 2,4-dinitrophenylhydrazones by addition of a 3- 
to 5-fold excess of a 0.1 To solution of 2,4-dinitrophenylhydrazine 
in 2 N HCl to the solutions containing the samples, filtration, and 
recrystallization of the hydrazone from a mixture of ethanol and 
2 N HCl. 
Analyses-2,4-Dinitrophenylhydrazone of oc-keto-fi-hydroxy- 
isovaleric acid 
Cn&O,N4 (312.2) 
Calculated: C 42.4, H 3.85, N 17.9 
Found : C 42.5, H 3.86, N 18.2 
2,4-Dinitrophenylhydrazone of ar-keto-fi-hydroxy-fl-methylva- 
leric acid. 
C&d&N4 (326.3) 
Calculated: C 44.2, H 4.30, N 17.2 
Found : C 44.02, H 4.28, N 17.09 
Reduction of the dinitrophenylhydrazones with hydrogen over 
platinum oxide at 30 pounds per sq. inch yielded a mixture of the 
corresponding cY-amino-fi-hydroxy acids and the a-amino acids, 
the latter resulting from reduction of the hydroxyl group. This 
behavior is analogous to that observed by Meister and Abend- 
schein (9) for the dinitrophenylhydrazones of ol-keto-P-hydroxy- 
butyric acid and hydroxypyruvic acid. 
Solutions of the sodium salts of the two ketohydroxy acids are 
stable at -16’ for extended periods. Treatment at 100’ for 5 
minutes caused no apparent destruction as judged by keto acid 
assay with 2,4-dinitrophenylhydrazine. 
Other Chemicals-cY-Acetolactate, cr-aceto-a-hydroxybutyrate, 
and acetoin were prepared as described elsewhere (1). Glucose 
6 - phosphate (Sigma), 6 - phosphogluconate (Sigma), TPN 
(Sigma), DPNH (Sigma), and protamine sulfate (Eli Lilly) were 
commercial products, Hydroxypyruvic acid was prepared as de- 
scribed by Sprinson and Chargaff (7). The TPNH used rou- 
tinely was prepared enzymatically from TPN, glucose B-phos- 
phate, and glucose g-phosphate dehydrogenase. Highly active 
preparations of the latter enzyme were obtained by fractionation 
of crude buffer extracts of N. crassa (10). These were free of 
the enzyme that forms acetolactate from pyruvate (1)) of B-phos- 
phogluconate dehydrogenase, and of the reductase and reducto- 
isomerase studied below. 
Assay of wKeto-/3-hydroxy Acid Red&use-Reductase activity 
was assayed by the decrease in absorbancy at 340 rnp in a mix- 
ture containing the following : cw-keto-fl-hydroxyisovalerate, 10 
pmoles; TPNH, 0.1 pmole; enzyme, and Tris buffer (final con- 
centration, 0.1 M) pH 7.5, in a total volume of 1.0 ml. Changes 
in optical density were followed in the Cary recording spectro- 
photometer. One unit of activity was defined as that amount of 
enzyme which produced a decrease in optical density of 0.1 in 5 
minutes at 25” in the above assay mixture. For comparative 
purposes, most assays also were run with cr-keto-&hydroxy#- 
methylvalerate (5 pmoles) replacing a-keto-fl-hydroxyisovalerate 
as substrate. 
Assay of cY-Hydroxy-P-keto Acid Reductoisomerase-The con- 
ditions were the same as those specified above, but oc-aceto-cr-hy- 
droxybutyrate (20 pmoles) replaced the cr-keto-fl-hydroxy acids 
* The “expected” amount of COZ was calculated on the basis of 
the amount of bromoketo acid hydrolyzed. Decarboxylation 
with HzOz was less satisfactory because of an anomalous continu- 
ous evolution of gas, over and above the expected values, perhaps 
due to nonenzymatic breakdown of HzOz. The assays with ceric 
sulfate were further checked by enzymatic assay of the products 
in the presence of an excess of the a-keto-P-hydroxy acid reductase 
and TPNH. 
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FIG. 1. Reactions involved in biosynthesis of valine. Reac- 
tions demonstrated in cell-free extracts are indicated by solid 
arrows. 
TABLE I 
Purification of a-keto-phydroxy acid reductase from extracts of 
N. crassa 
Fraction Volume Protein Reductase activity* Recovery 
ml w/ml units/nag protein 
A 278 19.0 12.1 
B 280 5.45 37.0 88.5 
C 312 3.28 53.0 85.0 
D 25 13.1 128 65.5 
E 16 2.8 330 23.3 
* a-Keto-fl-hydroxyisovalerate as substrate. The summation 
of the activities of individual fractions frequently was greater 
than that of the starting material (e.g. C + D > A) for unknown 
reasons. 
as substrate, and /%mercaptoethanol (5 pmoles, MgS04 (2.5) 
pmoles), and a boiled extract of N. crassa or of E. coli (0.05 ml) 
were added. The latter extracts were the supernatant fluids 
obtained by heating the crude extracts of these organisms used 
for enzyme preparation (1) at 100’ for 5 minutes, then centrifug- 
ing. 
Protein was determined by the procedure of Lowry et al. (11). 
RESULTS 
Fractionation and Separation of Reductase and Reductoisomerase 
From N. crassa-Two procedures were evolved. In Procedure 
1, crude water extracts (Fraction A, Table I) of N. crassa were 
treated with 0.05 M AlCl, as described elsewhere (1). After 5 
minutes, the heavy precipitate was centrifuged out and dis- 
carded.3 The supernatant solution (Fraction B) was adjusted to 
pH 7.0 and fractionated at O-5” by addition of solid ammonium 
sulfate.4 Fraction C was precipitated by adding ammonium sul- 
fate to 50% saturation. Most of the activity was present in the 
fraction soluble in SOTo, but insoluble in SO%, saturated ammo- 
nium sulfate (Fraction D, Table I). Further purification of 
Fraction D with alumina gel CT by the procedure of Ochoa et al. 
(13) as described below for the enzyme from E. coli, gave frac- 
tions (E, Table I) with specific activities as high as 330 units per 
mg of protein. 
3 This procedure provides a convenient means for separating the 
reductases from the acetolactate-forming enzyme, which precipi- 
tates at this step (1). 
4 Additions of solid ammonium sulfate were made in the 
amounts specified for room temperature (12) and were not cor- 
rected for temperature. 
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pH 7.0) was treated first with protamine sulfate, then fraction- 
ated with ammonium sulfate as described for N. crassa. The 
fraction insoluble between 40 and 70 To saturation was redissolved 
in 61 ml of 0.1 M phosphate buffer pH 7.5, and fractions precipi- 
tating between O-45, 45-50, 50-55, and 5560% saturation with 
ammonium sulfate were collected.4 The fractions highest in re- 
ductase activity also were high in reductoisomerase activity (Ta- 
ble III). 
TABLE III 
Purijication and separation of wketo-fi-hydroxy acid reductase from 
reductoisomerase of E. coli 
TABLE II 
Separation of a-keto-b-hydroxy acid reductase from 
reductoisomerase of N. crassa 
- 
Reductiosomer- 
ase (AHB) 
- 
Fraction Protein - 
pecific 
ctivity 
ml 
400 
440 
w/ml 
12.2 
9.0 
2.7 
5.6 
~- 
<ecov- Specific 
-Y activity 
-- 
% 
100) 6.0 
170 5.9 
42.5 17.3 20 113 0 
46 21.8 0 7.6 
20 1.0 48 15.9 0 
20 0.71 80 18.4 0 
,- .- 
% 
(100) 
79 
32 
1. Crude extra&t 
2. Protamine-treated 
Fraction 1 
3. Ammonium sulfate 
a. 50-60% 
b. SO-SO% 
4. Gel fractions$ 
7 
8 
T T Reductoisomer- ase (AHB) 
Protein 
Specific Recov- Specific Recov- 
activity -Y activity =Y 
Fractions Volume 
1 
ml m-m 
350 15.5 
390 10.6 
22 
26 
61 35 49 88 36 101 
42.7 8.1 111 32 126 58 
36.6 6.5 128 26 35.4 11 
42.7 1.28 262 
128 1.25 186 
42.7 0.58 0 
* Assayed also with HKI as substrate. No tendency of the 
activities toward KHV and HKI to separate was noted. The 
average ratio of activities, KHV:HKI = 1.04, was distinctly 
lower than that observed for the corresponding enzyme from 
E. coli. For abbreviations, see footnote 1 in text. 
t The activity of the crude extract used here was substantially 
lower than usual (cf. Table I) for unknown reasons. 
$ See text. 
1. Crude extract 
2. Protamine-treated 
Fraction 1 
3. Ammonium sulfate 
a. 4&70% 
b. 50-55% 
c. 55-60% 
4. Gel fractionst 
1 
2-4 
5 
In Procedure 2, the crude buffer extract of N. crassa (400 ml, 
5.2 g of protein, pH 7.0) was treated with 52 ml of a 1.5oj, solu- 
tion of protamine sulfate in 0.1 M potassium phosphate buffer, pH 
7.0. The mixture was stirred for 15 minutes, then centrifuged at 
18,000 x g for 15 minutes, and the residue discarded. The su- 
pernatant solution was further fractionated with ammonium sul- 
fate at O-5” to yield fractions insoluble between 0 and 30, 30 and 
40, 40 and 50, 50 and 60, and 60 and 90% saturation.4 After 
each addition of ammonium sulfate, the pH was readjusted to 
7.0 and the mixture was stirred for 30 minutes before the pre- 
cipitated protein was centrifuged out. The precipitates were 
dissolved in each case in 0.1 M Tris buffer pH 7.5, for assay. 
Results (Table II) show that, as in Procedure 1, most of the re- 
ductase for cr-keto-/3-hydroxyisovalerate was present in the 50- 
60% fraction. Of greater interest was the absence of all reduc- 
toisomerase activity from this fraction. This latter enzyme is 
present in the 60-90s fraction. Twenty milliliters of the 50- 
60% fraction were dialyzed for 9 hours between 0 and 5” to re- 
move ammonium sulfate. The dialyzed solution was then ad- 
justed to 35 ml and pH 6.5 and subjected to fractional absorption 
in eight steps with 2 ml of alumina gel CT at each step, in the 
manner described below for E. coli. In the most active fraction 
(Table II) the reductase was purified about 30-fold over the crude 
extract, a degree of purification similar to that achieved by Pro- 
cedure 1. Only by Procedure 2, however, was the reductase 
freed of reductoisomerase. Further purification of the reducto- 
isomerase of N. crassa proved difficult. Heavy losses without 
purification occurred on dialysis against buffer containing Mg++ 
and /3-mercaptoethanol, and upon gel fractionation. The prop- 
erties of this enzyme were, therefore, determined with the 60-90 ‘% 
fraction described in Table II. 
From E. coli: (a) Protamine and Ammonium Sulfate Treatment 
-Cells of E. coli K-12 grown in minimal salts-glucose medium 
(14) were disrupted in the magnetostriction apparatus as de- 
scribed elsewhere (1). This extract (350 ml, 5.95 g of protein, 
* The reductase was assayed also with HKI as substrate. In 
no case was there any indication of separation of the activities 
toward HKV and HKI. The average ratio of activities on the 
two substrates (HKV:HKI) was 1.9. For abbreviations, see 
footnote 1 in text. 
t Prepared from dialyzed 50-55yo ammonium sulfate Fraction 
3b. The data given for Fractions 2-4 are the averages of values 
found for the individual fractions. 
PH 
FIG. 2. The relation of pH to activity of the purified cu-keto-8- 
hydroxy acid reductase. Standard assay procedure (see text) 
with pH varied. The enzyme from E. coli was 25.6 pg of protein 
from Gel fraction 1 (Table III); that from N. crassa, 250 pg of 
protein from the 50-60% (NH,),SOa fraction (Table II). For key 
to abbreviations, see text footnote 1. 
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SUBSTRATE, MOLARITY X I03 
FIG. 3. The relation of substrate concentration to activity of the cu-keto-@-hydroxy acid reductase. The inserts show Lineweaver, 
Burk plots of the same data. Reaction mixtures as in Fig. 2 with substrate concentration varied and pH constant at 7.5. A and B- 
enzyme from E. co&i (154 pg of protein from the 50-5570 fraction, Table III); C, enzyme from N. Arabia as specified in Fig. 2. For 
abbreviations, see text footnote 1. 
(b) Gel Treatment-Twenty milliliters of Fraction 3b (Table 
III) were dialyzed for 9 hours at O-5” against 6 liters of 0.005 M 
phosphate buffer pH 7.5, containing MgS04 (1 X 10e4 M) and 
@-mercaptoethanol (1 X lo-* M). Heavy losses of the cu-hy- 
droxy+keto acid reductoisomerase occurred in the absence of 
Mg++. The cw-keto-P-hydroxy acid reductase, in contrast, is 
quite stable towards dialysis in the absence of Mg++. 
The dialyzed fraction (22 ml; 154 mg protein) was adjusted to 
pH 6.0 by careful addition of 0.1 N acetic acid, and was subjected 
to fractional adsorption on alumina gel Gy in six steps by the 
general procedure of Ochoa et al. (13). A gel suspension (1.6 ml) 
containing 7.5 mg of solids per ml was placed in each of six cen- 
trifuge tubes. Each of these was centrifuged just before use and 
the supernatant fluid was decanted. The enzyme solution was 
added to the first of the gel tubes, stirred for 15 minutes, and 
centrifuged. The gel precipitate was eluted with 20 ml of 0.2 
M phosphate buffer pH 8.0, for 1 hour with continuous stirring. 
The supernatant fluid containing the unabsorbed proteins from 
the first gel treatment was transferred to the second tube of gel, 
and the treatment repeated. In this way six gel eluates and one 
supernatant solution from the last gel treatment were obtained. 
Activities of certain fractions obtained by this procedure are given 
in Table III. Unlike the reductoisomerase of N. crussu, that of 
E. coli was stable both to dialysis in the presence of Mg++ and 
to the gel fractionation, and is substantially purified by these 
procedures. Gel eluate 1 is high in reductase activity and con- 
tains little of the reductoisomerase. It was used for further 
studies of the cu-keto-/3-hydroxy acid reductase of E. COG. Gel 
eluate 5, which is free of reductase activity, was used for most 
studies of the reductoisomerase. 
Properties of a-Keto-/3-hydroxy Acid Reductase 
pH Optimum and Afinity for Substrates-In none of the frac- 
tionation procedures was any tendency noted for the cr-keto-P- 
hydroxyisovalerate reductase to separate from the ar-keto-fi-hy- 
droxy$-methylvalerate reductase (see Tables II and III). The 
pH optimum for the reductase from E. coli is from 6.5 to 7.0; 
that for the enzyme from N. crussa is slightly higher at pH 7.0 
to 7.5 (Fig. 2). For each enzyme the optimum is the same for 
the two substrates, and at optimal substrate concentrations the 
activity is higher with cY-keto-fi-hydroxyisovalerate than with 
oc-keto-/3-hydroxy-/I-methylvalerate as substrate.6 It is note- 
worthy that the ratio of the activity with the former substrate to 
that with the latter is distinctly higher for the enzyme from E. 
coli (average 1.9, Table III) than for the enzyme from N. crassa 
(1.04, Table II). The enzyme from E. coli has a higher affinity 
for Lu-keto-b-hydroxyisovalerate than for a-keto-B-hydroxy-/3- 
methylvalerate, and is inhibited by high concentrations of the 
latter substrate (Fig. 3, A and B) ; the converse is true for the 
reductase from N. crassa (Fig. 3, C). It may be concluded that 
the same enzyme acts upon both substrates, but that the reduc- 
tases from the two organisms show significant, if minor, differ- 
ences in properties. 
Substrate and Pyridine Nucleotide SpecQicity-As shown by the 
separation of activities in Tables II and III, the ol-keto-p-hy- 
droxy acid reductases do not act upon the isomeric cr-hydroxy-/3- 
6 In making these comparisons it should be remembered that 
the a-keto-P-hydroxy-@-methylvalerate used was optically inac- 
tive and may have been a racemic mixture. The optical specific- 
ity of the reductase is not known. 
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TABLE IV 
Substrate and coenzyme specificity of a-keto+hydroxy acid 
reductase from N. crassa and E. coli 
Substrate* 
HKV 
HKV 
HKV 
HKV 
HKI 
HKI 
HP 
HP 
HP 
- 
/.lWLOl~S/nZl 
10.0 
1.0 
10.0 
1.0 
5.0 
5.0 
5.0 
1.0 
5.0 
TPNH 
TPNH 
DPNH 
DPNH 
TPNH 
DPNH 
TPNH 
TPNH 
DPNH 
R !ate of coenzyme oxida- 
1 tion? by reductase from 
N. crassa 
0.098 
0.048 
0.042 
0.032 
0.067 
0.059 
I 
E. coli 
0.234 
0.062 
0.065 
0.0095 
0.370 
0.234 
0.043 
* For abbreviations, see footnote 1 in text; HP = Hydroxy- 
pyruvate. 
t Decrease in optical density at 340 rnp during the first minute 
under standard assay conditions (see text). Enzyme prepara- 
tions used were samples of the Gel 7 fraction of Table II (100 pg 
protein) for N. crassa and of the Gel 1 fraction of Table III (94 
pg protein) for E. coli. Both preparations had been stored in the 
deep freeze for approximately 4 months before use for these 
comparisons, and had lost from 50 to 90% of their initial activity. 
keto acids, ar-acetolactate or ol-aceto-cY-hydroxybutyrate. The 
purified reductase from N. crassa also does not oxidize TPNH in 
the presence of pyruvate, oc-ketoisovalerate, ac-keto-b-methyl- 
valerate, or acetoin. Hydroxypyruvate, however, is reduced by 
the reductase from both organisms at rates approximately equal 
to those found for ac-keto-/3-hydroxyisovalerate (Table IV). 
TPNH is slightly superior to DPNH as hydrogen donor for the 
enzyme from N. crassu, and is markedly superior to DPNH for 
the enzyme from E. coli (Table IV). 
Inhibition of Reductase Activity by Commercial Preparations of 
TPNH-The reductase from N. crassa showed substantially 
higher activities when TPNH was generated enzymatically in 
the cuvette than when commercial preparations of TPNH, pre- 
pared by reduction with sodium hydrosulfite, were used. For 
example, with TPNH prepared from TPN, glucose g-phosphate 
and the glucose 6-phosphate dehydrogenase of N. crassa, a given 
preparation of the reductase from N. crassa showed 98.5 units 
of reductase activity per mg. of protein. The same preparation 
assayed 83.5 units per mg with enzymatically prepared TPNH 
from Sigma Chemical Company, but only 18.2, 12,1,7.6, and 25.6 
units per mg with four independent lots of TPNH from the same 
company prepared by reduction with sodium hydrosulfite. The 
cause of the inhibition by the latter samples of TPNH is un- 
known; it is not due to contaminating traces of Ba++ or to un- 
changed hydrosulfite. 
Products of Reaction-The products formed from oc-keto- 
&hydroxyisovalerate and cr-keto-/3-hydroxy-fl-methylvalerate 
through action of the reductase from N. crassa have been identi- 
fied previously (6) by chromatographic techniques and by isola- 
tion as the direct reduction products, (Y ,P-dihydroxyisovaleric 
acid and (Y ,P-dihydroxy-fi-methylvaleric acid, respectively. By 
similar techniques, the same compounds were identified as prod- 
ucts of the reaction catalyzed by the purified reductase from E. 
COG. 
Equilibrium of Reaction-With the use of various reductase 
preparations from N. crassu, repeated efforts to demonstrate the 
reversibility of. the reaction have failed. In the presence of an 
excess of either of the cr-keto-/3-hydroxy acids, the oxidation of 
TPNH proceeds to completion. Starting from a, P-dihydroxy- 
@-methylvalerate or o( ,&dihydroxyisovalerate, no reduction of 
TPN could be detected even at pH values of 8 to 10, which 
should favor reversal of Reaction III (Fig. 1) by reducing the 
hydrogen ion concentration. Similarly, no reversal of the re- 
action occurred when continual regeneration of TPN was made 
possible by addition of oxidized glutathione and glutathione re- 
ductase.6 It was concluded that the reduction of the two a-keto- 
P-hydroxy acids to the corresponding a&dihydroxy acids is es- 
sentially irreversible. 
Despite this apparent irreversibility of the reduction, small 
quantities of keto acids with RF values of cr-keto-P-hydroxyiso- 
valerate and cr-keto-/3-hydroxy-/?-methylvalerate were isolated 
from the culture fluids of N. crussu. For this purpose, 1 liter of 
medium from a a-day culture of N. crassa 16117 (1) was evapo- 
rated to 50 ml, acidified with sulfuric acid, and extracted con- 
tinuously for 24 hours with ether. The ether extract was evap- 
orated and the residue was applied as a streak across Whatman 
No. 3 paper. After development with water-saturated ether- 
benzene-formic acid (70 :30: 14, by volume), two separate zones 
corresponding in position to authentic cr-keto&hydroxyisova- 
erate and a-keto-P-hydroxy-fi-methylvalerate were eluted with 
water. These ketohydroxy acids were heavily contaminated 
with the corresponding dihydroxy acids (detected as described in 
(6)), but not with cr-ketoisovalerate or ar-keto-&methylvalerate. 
Each eluate contained material that was reduced with purified 
reductase and TPNH. On treatment with 2,4-dinitrophenylhy- 
drazine, hydrazones were formed which had chromatographic 
properties identical with authentic reference samples prepared 
from synthetic ol-keto-P-hydroxyisovalerate and from ar-keto-/I- 
hydroxy-fi-methylvalerate. Like the 2,4-dinitrophenylhydra- 
zones of the authentic a-keto-P-hydroxy acids, those prepared 
from the eluates were reduced catalytically to give a mixture of 
the corresponding hydroxyamino acids and the parent amino 
acids. It is concluded that in some mutant cultures, small 
amounts (approximately 5 mg per liter of medium) of cY-keto-/I- 
hydroxyisovalerate and cY-keto&hydroxy-fl-methylvalerate are 
formed and appear in the culture medium. 
Miscellaneous Properties-Oxidation of TPNH was directly 
proportional to reductase concentration for preparations from 
both N. crassa and E. coli. In contrast to that of the reducto- 
isomerase, activity of the purified reductase was not influenced 
by Mg++, Mn++, /3-mercaptoethanol, or by boiled crude extracts 
of tissues, and the enzyme is stable to dialysis. 
Distribution of Reductase in Biological Materials-The reduc- 
tase was present to an approximately equal extent in wild type 
Neurospora or E. coli, which synthesize valine and isoleucine, and 
in several valineless, isoleucineless mutants of these organisms. 
Several animal tissues contain a similar enzyme (Table V). 
Effect of Cultural Conditions on Red&use Activity of N. crassa 
and E. coli-Production of the reductase was not inhibited by 
addition of valine or isoleucine to the culture medium of either 
N. crassa or E. co2i (Table VI). The reductase activity of these 
cultures is maximal at valine and isoleucine concentrations nor- 
mally used for growth of the mutant cultures. The specific ac- 
tivity of the cell extracts varied only slightly (=tlO%) with varia- 
6 The purified reductase fractions from N. crassa contained a 
highly active glutathione reductase. 
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tions in incubation time between 45 and 84 hours for N. crassa 
16117 or between 12 and 24 hours for E. coli K-12. 
Properties of or-Hydroxy-/3-keto Acid Reductoisomerase 
As seen in Tables II and III, the cu-keto-P-hydroxy acid reduc- 
tase of both N. crassa and E. coli has been almost completely 
separated from an enzyme shown below to catalyze Reaction IV, 
Fig. 1. Properties of the latter enzyme, the reductoisomerase, 
are as follows. 
Cofactor and Metal Ion Reyuirements-TPNH was required for 
enzymatic activity (Table VII) and could not be replaced by 
DPNH. The enzyme also shows an obligatory requirement for 
a metal ion (Table VII). A purified enzyme fraction that showed 
45 units per mg of activity with MgSOl supplied at a concentra- 
tion of lo-* M showed only 8.5, 7.5, and 5.5 units per mg of pro- 
tein when Al, Ni, or Cu salts, respectively, were substituted for 
1Llg++-, at equimolar concentrations, and showed no activity when 
Mg++ was replaced by Ca++, Mn++, Fe++, Zn++, Cd++, or Hg++ 
at this level. Thus, only Mg++ is highly active; it shows optimal 
TABLE V 
Distribution of wketo-8-hydroxy acid reductase activity in nature 
TABLE VII 
Requirements for activity of purijied reductoisomerase of E. coli 
and of N. crassa 
Activity, units per mg of proteinf 
Omissions from complete assay system* E. coli 
N. crassa 
kperiment 
2 
1010 11.2 
0 0 
0 0 
198 5.2 
710 10.1 
710 8.8 
585 8.4 
198 4.0 
0 4.0 
0 3.1 
kperiment 
1 
124 
0 
0 
25 
55 
18 
0 
0 
- 
None. 
a-Aceto-a-hydroxybutyrate., 
TPNH. . 
Mg++ . . 
/%Mercaptoethanol (RSH) 
Boiled crude extract (BCE) 
RSH + BCE.. 
Mg++ + RSH. 
Mg++ + BCE. . 
Mg++ + RSH + BCE. 
* The complete assay system was that described in the text. 
t Enzyme fractions used (per ml of assay mixture) were as 
follows: E. coli, Experiment 1, 100 pg of protein from 5&5501, 
fraction (Table III); Experiment 2, 12 rg of protein from Gel 5 
fraction of Table III; N. crassa, 1OOpg of protein from the S&90% 
fraction, Table II. 
Reductase 
activity* SOUW? 
Reductase 
activity* 
units/mg 
protein 
Guinea pig liver 3.0 
Human liver 0.0 
Mouse liver 1.9 
Rabbit liver 2.3 
Rat liver 10.0 
Sheep kidney 1.5 
Beef brain 0.0 
Human brain 0.0 
SOUKX 
units/mg 
fir&in 
16.1 
19.7 
11.9 
12.7 
17.5 
12.3 
9.6 
N. crassa 
Em 5256 (wild type) 
16117 (mutant) 
16117-25 (mutant) 
T304 (mutant) 
7110 (mutant) 
E. coli 
K-12 (wild type) 
413 (K-12 mutant) 
1 
* Cultures were grown and cell-fre e extracts prepared as de- 
scribed previously (1). Animal tissues were homogenized and 
centrifuged, and the supernatant solutions tested. a-Keto-p- 
hydroxyisovalerate was the substrate; assay conditions were 
those specified in the text. 
M9 *, MOLARITY X IO3 
TABLE VI 
Effect of valine and isoleucine concentration on a-keto-&hydroxy 
acid reductase activity of N. crassa and E. coli 
FIG. 4. Activation of the reductoisomerase of E. coli by Mg++. 
Assay mixture as specified in text with Mg++ omitted and 77 fig 
of protein from the 50-557, fraction (Table III) present as the 
enzyme. Reductase activity 
Organism and strain DL-Valine/DL-Isoleucine 
Units per mg 
of protein 
1 Jnits per liter 
of culture* 
mg/liter 
o/o 
15/5 
30/10 
470/200 
16.1 7,900 
7.6 150 
13.2 820 
16.1 10,800 
o/o 12.3 3,580 
15/15 20.0 1,375 
activity at 2.5 x 1O-3 M and is somewhat inhibitory at high con- 
centrations (Fig. 4). /3-Mercaptoethanol and a boiled crude ex- 
tract of E. coli or of N. crassa increase the observed enzyme ac- 
tivity (Table VII). The nature of the stimulation by the boiled 
crude extract is not known. It was frequently not observed in 
extracts held in the frozen state for long periods. Additions of 
adenosine triphosphate, coenzyme A, tetrahydropteroylglutamic 
acid and the vitamin Biz coenzyme (15) had no effect. High 
concentrations of ATP inhibited the reaction, possibly by binding 
the Mg++. 
Effect of pH and Substrate Concentration-The pH optimum is 
near 7.5 both for the enzyme from E. coli and for that from N. 
crassa (Fig. 5). The effect of concentration of cu-aceto-a-hy- 
droxybutyrate and oc-acetolactate on formation of the rearranged 
and reduced products by the purified enzyme from E. coli is 
- 
N. crassa 
Em 5256 
16117 
16117 
16117 
E. coli 
K-12 
413 
* None of the reductase activity was detected in the cell-free 
culture filtrate. The values in this column represent the product 
of Column 3 and the mg of protein obtained by extraction of the 
cells from 1 liter of culture medium. 
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lx 
if 
0 
P 6.0 7.0 8.0 9.0 z 2 
3 PH z 
J 
FIG. 5. The effect of pH on the activity of the reductoisomerase 
of E. coli and N. crassa. Curves 1 and ,??, purified preparations 
from E. coli with Tris and phosphate buffers, respectively. Curve 
S, purified preparation from N. crassa, Tris buffer. The assay 
mixture was that specified in the text with the buffer varied. 
0’ I 
0 5 
’ 14 
IO 20 
SUBSTRATE, MOLARITY x I03 
FIG. 6. The effect of substrate concentration on the activity of 
the reductoisomerase from E. coli. A purified gel fraction (Table 
III) was the enzyme source and experiments with both substrates 
were run in parallel. Assay as in text with substrate varied. 
AHB = or-aceto-a-hydroxybutyrate; AL = a-acetolactate. 
e 
2 
F 
O- I I ’ Id 
0 5.0 IO 
P a-ACETO-a-HYDROXYBUTYRATE 
5 (MOLARITY X IO31 
FIG. 7. The effect of concentration of a-aceto-a-hydroxybutyr- 
ate on the activity of the reductoisomerase from N. crassa. 
Assay as in Fig. 6. 
shown in Fig. 6. The activity of the enzyme is much higher with 
acetohydroxybutyrate than with acetolactate as substrate, al- 
though the affinity for the two substrates is similar. Fig. 7 gives 
similar data for the purified reductoisomerase of N. crassa. 
Identijication of Products-The product of the reaction cat- 
alyzed by the purified reductoisomerase from E. coli with 
cr-aceto-ol-hydroxybutyrate as substrate was identified as (Y ,@- 
dihydroxy-fl-methylvaleric acid and not the direct reduction 
product, (Y ,/I-dihydroxy-cu-ethylbutyric acid. For this purpose, 1 
ml of Gel eluate 5 (Table III), 200 pmoles of a-aceto-cY-hydroxy- 
butyrate, 25 pmoles of Mg ++, 50 pmoles of @-mercaptoethanol, 
0.2 pmole of TPN, 100 pmoles of glucose 6-phosphate, 0.2 ml of 
purified glucose g-phosphate dehydrogenase from N. crassa (lo), 
0.5 ml of boiled E. coli extract, and 600 pmoles of Tris in a total 
volume of 10.0 ml were incubated at pH 7.5 for 6 hours at 37” 
under a thin layer of toluene. The mixture was evaporated to 
dryness and acidified with a few drops of 6 N HCl. An amount 
of solid sodium sulfate sufficient to absorb the water was added, 
and the free acid was extracted into ether. The ether extract 
was evaporated, and the residue was dissolved in a small amount 
of ethanol and applied as a streak on one sheet of Whatman No. 
3 paper. The chromatogram was developed with the ether-ben- 
zene-formic acid solvent (6, 18). A single dihydroxy acid was 
detected by spraying guide strips with periodate-benzidine rea- 
gent. This acid was eluted from the unsprayed region and neu- 
tralized with 0.01 N NaOH. Both the direct titration value and 
the value afforded by the procedure of Adelberg (16) gave a to- 
tal of 40.0 pmoles of the isolated acid. After treatment with 
periodate, 2,4-dinitrophenylhydrazine (0.1%) in 2 N HCl was 
added. Glyoxylic acid and methyl ethyl ketone were identified 
as the sole products of oxidation by chromatography of the 2,4- 
dinitrophenylhydrazones against authentic standards. Glyox- 
ylic acid was further identified by means of the characteristic 
spectrum of its 2,4-dinitrophenylhydrazone in alkali (17). 
These oxidation products establish the isolated acid to be cx ,P-di- 
hydroxy-/3-methylvaleric acid. No oc-ketobutyrate or acetalde- 
hyde, the products formed on periodate treatment of the isomeric 
ar &dihydroxy-oc-ethylbutyric acid, were found.7 The isolated 
7 The direct reduction products of cu-acetolactate and of cu-aceto- 
a-hydroxybutyrate were prepared by subjecting solutions of these 
compounds in 0.1 M phosphate buffer, pH 8.0, to hydrogenation 
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TABLE VIII 
Comparison of a&v&es of reductase and reductoisomerase of E. coli 
and of N. crassa for their substrates 
a-Keto-p-hydroxyacid reduc- 
tase........................ 
cu-Keto-fl-hydroxyacid reduc- 
tase........................ 
Reductoisomerase 
Reductoisomerase 
Sub- 
strate* 
HKV 
HKI 
AHB 
AL 
Km values, moles per liter 
N. crassa 1 E. coli 
1.6 X 10-s 1.4 x lO-4t 
3.8 X IO-*? 6.7 X 1O-3 
8.1 X lo-” 7.25 X 1O-4 
6.5 X 1O-4 
* For abbreviations, see footnote 1 in text. 
t Substrate inhibition at, high levels. 
dihydroxy acid also was converted to isoleucine by a freshly pre- 
pared extract of N. crassa, wild type. For this purpose, the fol- 
lowing mixture was incubated for 9 hours at 37” with suitable 
controls: isolated (Y#-dihydroxy-/3-methylvalerate, 10 pmoles; 
extract of N. crassa, 1.0 ml; L-valine, 50 pmoles; pyridoxal phos- 
phate, 20 pg; ferrous sulfate, 5 pmoles; and Tris buffer pH 8.0, 
450 pmoles, in a total volume of 10 ml. Isoleucine was identi- 
fied and estimated by paper chromatography according to Giri 
et aZ. (19); 6.9 pmoles were found. 
By precisely similar methods, the product formed by action of 
the purified reductoisomerase from E. coli on a-acetolactate was 
identified as cy , /3-dihydroxyisovaleric acid; none of the isomeric 
product of direct reduction, CY, P-dihydroxy-cr-methylbutyric 
acid, was formed.7 
The same experiments were performed with a purified fraction 
from N. Arabia (Fraction D, Table I) high in the a-keto-p-hy- 
droxy acid reductase, but which also oxidized TPNH in the pres- 
ence of cr-acetolactate and ol-aceto-a-hydroxybutyrate. In the 
presence of the latter substrates, only (Y ,fi-dihydroxyisovalerate 
and CY ,&dihydroxy-fl-methylvalerate were formed; no trace of 
the direct reduction products which yield acetaldehyde, together 
with pyruvate or cY-keto-butyrate on periodate cleavage,’ was 
found. The reductoisomerase of N. crassa, therefore, like that 
of E. coli, carries out reduction only when accompanied by isom- 
erization. This latter experiment also confirms the conclusion 
drawn from the fractionation experiments, that the reductase 
present in these organisms cannot reduce the ac-hydroxy-@-keto 
acids isomeric with its natural substrates, the ar-keto-P-hydroxy 
acids. 
From Figs. 3, 6, and 7 the K, values for their substrates of the 
two enzymes studied here were calculated. These are sum- 
marized in Table VIII. Since the enzyme preparations are far 
from pure and since three of the four substrates tested are racemic 
mixtures, the values are of course only tentative. They demon- 
over platinum oxide at 30 pounds per sq. inch and room tempera- 
ture. In each of several solvent systems tested the reduction 
products migrated identically with the isomeric compounds, 
DHV and DHI. However, on treatment with periodate ~l,p- 
dihvdroxv-a-methvlbutvrate yielded pvruvate (detectable on 
paper chgomatograms ai its 2,4-dinitro$enylhydr&one) and was 
thus readilv distineuished from the isomeric DHV. which vielded 
glyoxylate “and a&one. Similarly, a,,8-dihydroxy-a-ethyibutyr- 
ate, the direct reduction product of cu-aceto-or-hydroxybutyrate, 
yielded a-ketobutyrate and acetaldehyde on periodate treatment, 
and was thus readily distinguished from the isomeric DHI, which 
yielded glyoxylate and methyl ethyl ketone. 
strate, nonetheless, interesting differences in the behavior of the 
cr-keto-P-hydroxy acid reductase from E. coli and that from N. 
crassa toward their substrates. 
DISCUSSION 
The wide distribution of the cr-keto-/3-hydroxy acid reductase, 
its substrate specificity, and the natural occurrence of its sub- 
strates under some conditions, all point to a specific role of this 
enzyme in metabolism. Whether it participates in reactions 
that normally lead to biosynthesis of isoleucine and valine in viva, 
however, remains to be decided. The evidence in favor of this 
view consists largely of the facts that (a) its substrates, cr-keto- 
@-hydroxyisovalerate and cY-keto$-hydroxy-fl-methylvalerate, 
are converted to valine and isoleucine, respectively, by enzymes 
acting in vitro, (b) its substrates replace the requirement for the 
amino acids in certain mutants of E. coli and of Salmonella that 
require isoleucine and valine,8 and (c) the oc-keto-P-hydroxy acids 
accumulate in small amounts in the medium of the Neurospora 
mutant, 16117, which also accumulates large quantities of the 
corresponding o(, /3-dihydroxy acids. This evidence cannot be 
considered as proof of the postulated relationship. The cr-aceto- 
a-hydroxy acid substrates are converted to the dihydroxy acids 
(Step IV, Fig. 1) by one enzyme fraction, the reductoisomerase, 
that is separable from the reductase, and with no evidence of 
formation of intermediate a-keto-fl-hydroxy acids (Step II, Fig. 
1). We have made repeated attempts to induce this enzyme to 
catalyze Reaction II by omitting TPNH from the reaction mix- 
ture. In no case has any formation of the ar-keto-P-hydroxy acids 
been observed. The failure of the reductoisomerase to reduce 
a-keto-&hydroxyisovalerate to the corresponding dihydroxy acid 
also suggests that its action in catalyzing Reaction IV, Fig. 1, is 
not a simple summation of Reactions II + III. 
These results may be interpreted to mean that the reducto- 
isomerase, catalyzing Step IV, is the natural enzyme for the syn- 
thesis of the dihydroxy acids, and that the enzyme with reductase 
activity only is not involved in the formation of isoleucine and 
valine in vivo. Its natural function may be the reduction of hy- 
droxypyruvic acid, a substrate for which it has been shown to 
have activity.g In line with our failure to observe formation of 
any free a-keto-P-hydroxy acids by either of the two enzymes 
studied here, it may be postulated that these acids either (a) are 
not intermediates and hence not formed in this sequence, or (b) 
are formed but normally remain bound to the enzyme surface 
and are not released into the environment except under unusual 
circumstances. 
An alternative explanation which incorporates parts of the 
above interpretation is that the reductase is an artifact resulting 
from the partial degradation of the reductoisomerase which in 
the process loses the isomerase but not the reductase function. 
Various maltreatments of the enzyme, carried out in an attempt 
to test this possibility (e.g. partial heat denaturation, exposure to 
extremes of pH, solution in and precipitation from solutions 
high in urea, etc.) simply reduced its activity without producing 
any of the reductase. However, support for this idea lies in re- 
sults from preliminary experiments which show that a purified 
8 Dr. R. P. Wagner and Dr. H. E. Umbarger, private communi- 
cation. 
9 Stafford et al. (20) have described a hydroxypyruvate reduc- 
tase (n-glycera,te dehydrogenase) from higher plants; its activity 
on related a-keto-b-hydroxy acids was not, examined. It differs 
from the reductase studied here in its specific requirement for 
DPNH. 
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reductoisomerase preparation with no initial reductase (Step III) 
activity gradually lost reductoisomerase activity while standing 
at -20” or 8”, and simultaneously gained activity for the reduc- 
tion of cr-keto-/3-methylisovaleric acid. The reductoisomerase 
activity was partially restored by dialysis of the “degraded” 
fraction against P-mercaptoethanol. Significantly, whereas the 
reductoisomerase activity increased, the reductase activity de- 
creased. 
These considerations indicate that the a-keto-P-hydroxy acid 
reductase activity in crude preparations is either (a) a degraded 
or incompletely formed reductoisomerase, or (b) a reductase with 
a role in metabolism other than the reduction of the postulated 
cr-keto-/?-hydroxy acid precursors of isoleucine and valine, or 
both. On the basis of the present data, we cannot affirm the 
existence of reductase as such in intact cells, but can be reason- 
ably certain that a reductoisomerase exists which is involved di- 
rectly in the biosynthesis of isoleucine and valine. The role of 
the a-keto$-hydroxy acids as enzyme-bound intermediates is 
indicated, but not proved. Their formation by rearrangement 
of the cw-hydroxy-/3-keto acids (Reaction II, Fig. 1) has its model 
in the base-catalyzed rearrangement of acyloins studied by Sharp 
and Miller (21) and by Curtin and Leskowitz (22), which is simi- 
lar to but intermediate in oxidation state between the well known 
benzylic acid and pinacol rearrangements. 
SUMMARY 
Bromination of cr-ketoisovaleric acid and a-keto-P-methyl- 
valeric acid and mild hydrolysis of the products yielded cY-keto-fi- 
hydroxyisovaleric acid and cu-keto-P-hydroxy-/3-methylvaleric 
acid, respectively. These compounds were characterized via 
their 2,4-dinitrophenylhydrazones and by oxidative decarboxyla- 
tion with ceric sulfate. 
In the presence of reduced triphosphopyridine nucleotide 
(TPNH), extracts of Neurospora crassa and Escherichia coli re- 
duce these a-keto-P-hydroxy acids to the corresponding dihy- 
droxy acids (Reaction III, Fig. 1). By ammonium sulfate and 
gel fractionation, this c&eto-/?-hydroxy acid reductase has been 
purified approximately 30-fold from N. crassa and about B-fold 
from E. coli. The procedure separates this enzyme from a sec- 
ond TPNH-dependent enzyme, termed ac-hydroxy-P-keto acid re- 
ductoismerase, that forms these same two dihydroxy acids by 
isomerization of the carbon chain and reduction of cr-acetolactate 
and cr-aceto-oc-hydroxybutyrate (Reaction IV, Fig. 1). The lat- 
ter enzyme was purified about 70.fold from E. coli. 
The reductase from N. crassa functions optimally between pH 
7.0 and 7.5 with TPNH as hydrogen donor; DPNH is utilized 
slightly less effectively. TPNH is not oxidized in the presence 
of pyruvate, cu-ketoisovalerate, acetoin, a-acetolactate, or OL- 
aceto-oL-hydroxybutyrate. At optimal concentrations, cr-keto-P- 
hydroxyisovalerate is reduced slightly faster than a-keto- 
P-hydroxy-/I-methylvalerate and at about the same rate as 
hydroxypyruvate. The reductase from E. coli resembles that 
from N. crussu, but functions optimally at a slightly lower pH 
(6.5 to 7.0), shows reversed affinities for or-keto-fl-hydroxyiso- 
valerate and cr-keto-/?-hydroxy-/3-methylvalerate, and reduces the 
former substrate at nearly twice the rate of the latter. It also 
reduces hydroxypyruvate rapidly and shows a pronounced prefer- 
ence for TPNH as hydrogen donor. Neither enzyme is lowered 
in cultures grown in the presence of excess valine and isoleucine. 
The reductoisomerases of both N. crassa and E. coli require 
TPNH and Mg++ for activity, function optimally at pH 7.5, and 
are activated slightly by /3-mercaptoethanol and (in fresh prep- 
arations) by a boiled extract of N. crassa or of E. coli. The en- 
zyme from E. coli acts upon ol-aceto-a-hydroxybutyrate about 
eight times as rapidly as upon or-acetolactate, although affinities 
are similar for the two substrates. The products were identified 
as a,/3-dihydroxy-P-methylvaleric acid and cr,fi-dihydroxyiso- 
valeric acid, respectively. None of the direct reduction products 
were found, and no evidence for reversibility of the reaction was 
obtained. All efforts to demonstrate that the reaction occurred 
by a preliminary isomerization of the substrate to an a-keto-/3- 
hydroxy acid (Reaction II, Fig. 1) followed by reduction of the 
latter compound (Reaction III, Fig. 1) failed. It is concluded 
that the ar-keto$-hydroxy acids normally are not formed as free 
intermediates in the biosynthesis of isoleucine and valine; if they 
serve any intermediate role in the isomerization-reduction reac- 
tion they normally must remain tightly bound to the enzyme 
surface. No decision is possible at present between this mecha- 
nism and a concerted reaction that would exclude even bound 
a-keto-/3-hydroxy acids as intermediates.lO Small amounts of 
cr-keto-fl-hydroxyisovalerate and ol-keto-@-hydroxy-P-methyl- 
valerate were accumulated in the culture medium of N. crassa 
16117, but their occurrence is not adequate evidence for the 
former mechanism, since these could arise by action of enzymes 
not studied here. 
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